1. CA125 suppresses amatuximab immune-effector function and elevated serum levels are associated with reduced clinical response in first line mesothelioma patients. Issue 7 (3rd July 2018) Authors: Nicolaides, Nicholas C.; Schweizer, Charles; Somers, Elizabeth B.; Wang, Wenquan; Fernando, Shawn; Ross, Erin N.; Grasso, Luigi; Hassan, Raffit; Kline, J. Bradford Journal: Cancer biology & therapy Issue: Volume 19:Issue 7(2018) Page Start: 622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Folate Receptor Alpha, Mesothelin and Megakaryocyte Potentiating Factor as Potential Serum Markers of Chronic Kidney Disease. Issue 9 (January 2014) Authors: Somers, Elizabeth B.; O'Shannessy, Daniel J. Journal: Biomarker insights Issue: Volume 2015:Issue 9(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression. Issue 8 (15th December 2015) Authors: Kurosaki, Akira; Hasegawa, Kosei; Kato, Tomomi; Abe, Kenji; Hanaoka, Tatsuya; Miyara, Akiko; O'Shannessy, Daniel J.; Somers, Elizabeth B.; Yasuda, Masanori; Sekino, Tetsuo; Fujiwara, Keiichi Journal: International journal of cancer Issue: Volume 138:Issue 8(2016:Apr. 15) Page Start: 1994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗